Burden and prevalence of prognostic factors for severe COVID-19 in Sweden

被引:0
|
作者
Katalin Gémes
Mats Talbäck
Karin Modig
Anders Ahlbom
Anita Berglund
Maria Feychting
Anthony A. Matthews
机构
[1] Karolinska Institutet,Unit of Epidemiology, Institute of Environmental Medicine
来源
European Journal of Epidemiology | 2020年 / 35卷
关键词
COVID-19; Prognostic factors; Burden of disease; Prevalence;
D O I
暂无
中图分类号
学科分类号
摘要
The World Health Organization and European Centre for Disease Prevention and Control suggest that individuals over the age of 70 years or with underlying cardiovascular disease, cancer, chronic obstructive pulmonary disease, asthma, or diabetes are at increased risk of severe COVID-19. However, the prevalence of these prognostic factors is unknown in many countries. We aimed to describe the burden and prevalence of prognostic factors of severe COVID-19 at national and county level in Sweden. We calculated the burden and prevalence of prognostic factors for severe COVID-19 based on records from the Swedish national health care and population registers for 3 years before 1st January 2016. 9,624,428 individuals were included in the study population. 22.1% had at least one prognostic factor for severe COVID-19 (2,131,319 individuals), and 1.6% had at least three factors (154,746 individuals). The prevalence of underlying medical conditions ranged from 0.8% with chronic obstructive pulmonary disease (78,516 individuals) to 7.4% with cardiovascular disease (708,090 individuals), and the county specific prevalence of at least one prognostic factor ranged from 19.2% in Stockholm (416,988 individuals) to 25.9% in Kalmar (60,005 individuals). We show that one in five individuals in Sweden is at increased risk of severe COVID-19. When compared with the critical care capacity at a local and national level, these results can aid authorities in optimally planning healthcare resources during the current pandemic. Findings can also be applied to underlying assumptions of disease burden in modelling efforts to support COVID-19 planning.
引用
收藏
页码:401 / 409
页数:8
相关论文
共 50 条
  • [31] Factors related to asymptomatic or severe COVID-19 infection
    Perez-Campos Mayoral, Eduardo
    Teresa Hernandez-Huerta, Maria
    Perez-Campos Mayoral, Laura
    Alberto Matias-Cervantes, Carlos
    Mayoral-Andrade, Gabriel
    Laguna Barrios, Luis Angel
    Perez-Campos, Eduardo
    MEDICAL HYPOTHESES, 2020, 144
  • [32] The clinical characteristics and risk factors for severe COVID-19 in patients with COVID-19 and tuberculosis coinfection
    Wang, Yang
    Chen, Yanping
    Gu, Lina
    Lou, Lixin
    Zhang, Jian
    Zhang, Kaiyu
    FRONTIERS IN MICROBIOLOGY, 2022, 13
  • [33] Prevalence and predictive value of hypocalcemia in severe COVID-19 patients
    Liu, Jingmei
    Han, Ping
    Wu, Jingwen
    Gong, Jin
    Tian, Dean
    JOURNAL OF INFECTION AND PUBLIC HEALTH, 2020, 13 (09) : 1224 - 1228
  • [34] Factors related to mortality of patients with COVID-19 who are admitted to the ICU: Prognostic mortality factors of COVID-19 patients
    alvarez-Macias, Alejandro
    ubeda-Iglesias, Alejandro
    Macias-Seda, Juana
    Gomez-Salgado, Juan
    MEDICINE, 2024, 103 (21) : E38266
  • [35] Prevalence and factors associated with healthcare avoidance during the COVID-19 pandemic among the Sami in Sweden: the SamiHET study
    Dresse, Menayit Tamrat
    Stoor, Jon Petter
    San Sebastian, Miguel
    Nilsson, Lena Maria
    INTERNATIONAL JOURNAL OF CIRCUMPOLAR HEALTH, 2023, 82 (01)
  • [36] Clinical characteristics and prognostic factors in COVID-19 patients aged ≥80 years
    Covino, Marcello
    De Matteis, Giuseppe
    Santoro, Michele
    Sabia, Luca
    Simeoni, Benedetta
    Candelli, Marcello
    Ojetti, Veronica
    Franceschi, Francesco
    GERIATRICS & GERONTOLOGY INTERNATIONAL, 2020, 20 (07) : 704 - 708
  • [37] Prognostic factors of patients with diabetes and Covid-19: evidence from the CORONADO study
    Smati-Grangeon, S.
    Tramunt, B.
    CORRESPONDANCES EN METABOLISMES HORMONES DIABETES ET NUTRITION, 2021, 25 (02): : 56 - 59
  • [38] COVID-19, severe asthma, and biologic
    Underner, M.
    Taille, C.
    Peiffer, G.
    Perriot, J.
    Jaafari, N.
    REVUE DES MALADIES RESPIRATOIRES, 2021, 38 (04) : 423 - 426
  • [39] The Burden of Hypercoagulability in COVID-19
    Kim, Madeleine
    George, Andrew
    Ganti, Latha
    Huang, Derrick
    Carman, Matthew
    TH OPEN, 2022, 06 (02) : e96 - e98
  • [40] The impacts of COVID-19 on childhood obesity: prevalence, contributing factors, and implications for management
    Kim, Min-Ji
    Kim, Minji
    Yoon, Ju Young
    Cheon, Chong Kun
    Yoo, Sukdong
    ANNALS OF PEDIATRIC ENDOCRINOLOGY & METABOLISM, 2024, 29 (03) : 174 - 181